Related Experiment Video

Updated: Jun 13, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Quality of heart failure management: a comparison of care between a comprehensive heart failure program and a general

Hannah Asghar1, Peter S Rahko

  • 1Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

Congestive Heart Failure (Greenwich, Conn.)
|April 24, 2010
PubMed

Insights

Heart failure clinicians (HFCs) and general cardiologists (GCs) adhere to guidelines for device and medication use. HFCs demonstrated higher medication intensity, indicating superior guideline adherence in treatment management.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines
  • Heart Failure Management

Background:

  • Adherence to established guidelines is crucial for optimal patient outcomes in heart failure (HF).
  • Variations in clinical practice may exist between specialists focusing on HF and general cardiologists.

Purpose of the Study:

  • To compare the adherence to 2005 American College of Cardiology/American Heart Association HF guidelines between heart failure clinicians (HFCs) and general cardiologists (GCs).
  • To evaluate guideline adherence for implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT), and HF medications.

Main Methods:

  • Retrospective review of 563 patients with HF and ejection fraction ≤35%.
  • Comparison of guideline adherence between 324 HFC patients and 239 GC patients.
  • Analysis included appropriate use of ICDs, CRT, and HF medications.

Main Results:

  • CRT guideline adherence was high and similar between HFCs (86%) and GCs (81%).
  • ICD implantation for primary arrhythmia prevention was significantly higher in HFCs (42%) vs GCs (25%).
  • HFCs utilized guideline-recommended beta-blockers more frequently (97% vs 82%) and at higher dose intensities for HF medications.

Conclusions:

  • Both HFCs and GCs demonstrate substantial adherence to HF guidelines for device and medication therapy.
  • HFCs exhibit superior adherence in medication management, particularly regarding higher dose intensity of key HF drugs.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...